Acetazolamide
- Strength
- 125 mg/1
- Form
- Tablet
- Class
- Carbonic Anhydrase Inhibitor
PD-Rx Pharmaceuticals, Inc.
Listed by Marlex Pharmaceuticals, Inc.
| Dosage form | Tablet |
|---|---|
| Route | Oral |
| Drug class | Carbonic Anhydrase Inhibitor |
| Approval route | ANDA — approved generic |
| NDC code | 10135-831 |
| FDA application | ANDA217197 |
| RxNorm concept | 197303 |
| Package sizes listed | 1 |
| Marketed since | February 2026 |
Same active ingredient, different manufacturer, strength or form. Products matching on both ingredient and strength are usually interchangeable — but confirm before switching, especially with modified-release forms.
PD-Rx Pharmaceuticals, Inc.
PD-Rx Pharmaceuticals, Inc.
Aarkish Pharmaceuticals NJ Inc.
AvPAK
acetazolamide sodium
Mylan Institutional LLC
Gland Pharma Limited
Zydus Pharmaceuticals (USA) Inc.
Zydus Pharmaceuticals (USA) Inc.
Information only, not medical advice. Nothing on this page indicates that a medication is safe or suitable for you. Speak to a prescriber or pharmacist before starting, stopping or switching any medicine.
Please don't share card details in chat.